MEDX Fact Sheet: Horizon Kinetics Medical ETF
Share
$36.64
close, Nov 18, 2026
Over the year to Nov 18, 2026, MEDX returned +12.4% in total and charged 0.85% a year.
- 1-year total return
- +12.4%
- to Nov 18, 2026
- Expense ratio
- 0.85%
- a year
- Net flow, 12 months to Jun 30, 2026
- −$1.8m
- monthly N-PORT basis to Jun 30, 2026
Growth of $10,000, 1 year
MEDX $11,236 +12.4% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.
Returns
WindowTotal return
1 month+2.0%
3 months−3.2%
Year to date+10.3%
1 year+12.4%
3 years+39.7%
Total return, distributions reinvested, each window to Nov 18, 2026.
Ten largest positions
HoldingWeight
Eli Lilly & Co18.46%
AbbVie Inc8.85%
Novartis AG6.89%
Johnson & Johnson5.59%
Alkermes PLC5.53%
AstraZeneca PLC4.99%
Ionis Pharmaceuticals Inc4.53%
Bristol-Myers Squibb Co4.42%
Merck & Co Inc3.96%
Amgen Inc3.91%
MEDX top ten by weight, 67.1% of the fund, of its 31 equity positions, from the holdings filed for Jun 30, 2026.
Facts
Equity fund · Actively managed · First traded Jan 31, 2023 · Benchmark Its own holdings, as of Jun 30, 2026; its prospectus names no index it tracks